Related Experiment Video
Updated: Aug 7, 2026

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
Osteosarcoma as a communication-driven disease: redefining tumor-bone signaling networks as therapeutic targets
Gabriele Ricciardi1,2, Vincenzo Fiorentino1,3, Pietro Tralongo1
1BIOMORF Department of Biomedical, Dental, Morphological and Functional Imaging Sciences, A.O.U. Policlinico "G.Martino"- Via Consolare Valeria 1, Messina, Italy.
Abstract:
Osteosarcoma (OS) is an aggressive primary bone malignancy characterized by high metastatic potential and limited therapeutic progress. Beyond genomic instability, accumulating evidence indicates that OS operates as a communication-driven disease in which dynamic intercellular signaling networks within the tumor microenvironment regulate tumor growth, immune evasion, metastatic dissemination, and therapy resistance. This review integrates current knowledge on immune cell crosstalk, extracellular vesicle-mediated signaling, soluble factors, and direct cell-cell interactions that coordinate local and systemic tumor progression. We discuss how these interconnected communication circuits shape the tumor immune microenvironment and sustain adaptive plasticity. Finally, we highlight emerging strategies aimed at disrupting pathological signaling networks, while acknowledging that many communication-targeted approaches remain at the preclinical stage or require further clinical validation. Framing OS as a communication-driven ecosystem provides a unifying conceptual model to identify novel therapeutic vulnerabilities.
Insights
Osteosarcoma (OS) is a communication-driven bone cancer. Targeting intercellular signaling networks in the tumor microenvironment offers new therapeutic strategies for this aggressive disease.
Area of Science:
- Oncology
- Cancer Biology
- Tumor Microenvironment
Background:
- Osteosarcoma (OS) is an aggressive bone cancer with high metastatic potential.
- Genomic instability alone doesn't explain OS; intercellular communication is key.
- The tumor microenvironment significantly influences OS progression and treatment resistance.
Purpose of the Study:
- To review the role of intercellular communication in Osteosarcoma.
- To integrate knowledge on signaling networks within the OS tumor microenvironment.
- To identify novel therapeutic vulnerabilities by framing OS as a communication-driven ecosystem.
Main Methods:
- Literature review integrating current knowledge on OS signaling.
- Analysis of immune cell crosstalk, extracellular vesicles, soluble factors, and direct cell-cell interactions.
- Discussion of how communication circuits shape the tumor immune microenvironment and plasticity.
Main Results:
- Intercellular signaling networks critically regulate OS growth, immune evasion, metastasis, and therapy resistance.
- Communication circuits coordinate local and systemic tumor progression.
- These networks shape the tumor immune microenvironment and drive adaptive plasticity.
Conclusions:
- Osteosarcoma progression is heavily influenced by complex intercellular communication.
- Disrupting these pathological signaling networks presents emerging therapeutic strategies.
- Further clinical validation is needed for many communication-targeted approaches in OS.
More Related Videos
11:15A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
07:31A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
Published on: May 3, 2021
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...